Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible.

Hutchinson, J. A., Govert, F., Riquelme, P., Brasen, J. H., Brem-Exner, B. G., Matthai, M., Schulze, M., Renders, L., Kunzendorf, Ulrich, Geissler, E. K. and Fandrich, F. (2009) Administration of donor-derived transplant acceptance-inducing cells to the recipients of renal transplants from deceased donors is technically feasible. Clinical Transplantation, 23 (1). pp. 140-145.

Full text not available from this repository.

Abstract

Patient KW, a 36-yr-old male renal transplant recipient, received transplant acceptance-inducing cells (TAICs) as an adjunct immunosuppressive therapy. In the weeks post-transplantation, the patient's conventional immunosuppressive treatment was gradually minimized, such that, from the 21st wk post-transplantation onwards, the patient was stably maintained on tacrolimus monotherapy. Treatment with TAICs was without complication, both at the time of administration and in the four-yr follow-up period. It is concluded that the production and administration of TAICs to recipients of kidney transplants from deceased donors is technically feasible.

Document Type: Article
Keywords: cell-based immunotherapyregulatory macrophage tacrolimus monotherapy stem-cells immunosuppression macrophages induction tolerance spleen rat repopulation kinetics
Research affiliation: OceanRep > The Future Ocean - Cluster of Excellence
?? med ??
Refereed: Yes
Open Access Journal?: No
ISSN: 0902-0063
Projects: Future Ocean
Date Deposited: 11 Feb 2011 12:16
Last Modified: 14 Sep 2016 09:35
URI: http://oceanrep.geomar.de/id/eprint/9468

Actions (login required)

View Item View Item